Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Tocilizumab) Amendment Instrument 2021

I, Jane Cook, as delegate of the Minister for Health and Aged Care, make the following instrument.

Dated 17 December 2021

Dr Jane Cook

First Assistant Secretary
Medicines Regulation Division
Health Products Regulation Group
Department of Health

Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Tocilizumab) Instrument 2021

1  Name

  This instrument is the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Tocilizumab) Amendment Instrument 2021.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under section 30EK of the Therapeutic Goods Act 1989.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Tocilizumab) Instrument 2021

1  Section 7

Repeal the section, substitute:

7  Period instrument in force

  This instrument remains in force until 30 April 2022.